Scientists have turned an old idea on its head. A new paper reports that stretches of so-called “junk DNA” can help injured ...

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new ...

The fish that limbed vertebrates evolved from don't have obvious digit equivalents, and the most common types of fish just ...

The possibility of living dramatically longer lives has moved from science fiction to active debate among leading researchers. According to Scientific American, genetic advances are rapidly revealing ...

Targeted DNA editing by CRISPR technology has great potential for applications in biotechnology and gene therapy. However, precise gene editing remains a challenge largely due to insufficient control ...

When environmental stress harms DNA, it can set off a cascade of failures linked to heart conditions, neurodegeneration, and chronic inflammation. A new chemical tool developed at UC Riverside ...

Viewer-submitted questions for The Car Doctor: Q: I test drove a 2003 Honda Element (with only 50,000 miles) for about 10 minutes at speeds up to 55 mph. It drove like new and was in perfect condition ...

Macquarie University researchers have discovered a naturally occurring protein found in human cells plays a powerful role in repairing damaged DNA—the molecule that carries the genetic instructions ...

Francesca Storici consults at Tessera Therapeutics. She has received funding from the National Institutes of Health and the National Science Foundation. Your DNA is continually damaged by sources both ...

Plant genome editing through CRISPR-Cas holds transformative potential, yet its precision remains hampered by low gene targeting (GT) efficiency. This study presents a strategy to enhance CRISPR-based ...

Unlock your Potential with Best Repair tips ever! Renovation Secrets for Everyone #repair #tips #home #hacks Iran uses Trump's own words against him Here's what your student loan bill could be under ...

NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.